Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient

Nov 17 2024
Convention Center: Ballroom 20 A
12:30 PM - 2:00 PM

World Class Speakers

Naim Alkhouri
Industry Presenter

Naim Alkhouri

Arizona Liver Health
Meena B Bansal, MD, FAASLD
Industry Presenter

Meena B Bansal, MD, FAASLD

Icahn School of Medicine at Mount Sinai (ISMMS)
Mary Rinella
Industry Presenter

Mary Rinella

The University of Chicago

Description

This symposium will provide practical, interactive discussions of cardiometabolic pathophysiologic pathways, early identification and risk stratification, advances in treatment, monitoring for disease progression, and long-term medical management, including the role of incretin agonists.  

Supported by: This activity is supported by an independent educational grant from Madrigal Pharmaceuticals. 
Organizer: Prova Education

For more information and to register, visit: http://www.ReachMD.com/segment/26614

Objectives

  • Take the appropriate action in a patient with risk factors for MASLD/MASH and a given risk stratification score
  • Demonstrate best practices for management of patients with MASLD
  • Select an appropriate treatment strategy for a patient with at-risk MASH